GITNUXREPORT 2025

Diversity, Equity, And Inclusion In The Life Sciences Industry Statistics

Life sciences industry enhances innovation through increased diversity and inclusion initiatives.

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Statistic 1

Minority representation in biotech executive roles is around 10%

Statistic 2

Only 12% of drug researchers are from underrepresented racial and ethnic groups

Statistic 3

22% of biotech firms have explicitly stated targets for increasing diversity in their leadership

Statistic 4

73% of life sciences companies have implemented DEI training programs

Statistic 5

Only 11% of senior management positions in life sciences are held by people from underrepresented backgrounds

Statistic 6

The percentage of Black employees in the biotech industry is approximately 4%

Statistic 7

The average tenure of minority executives in biotech is 2.8 years, shorter than their non-minority counterparts by 1.5 years

Statistic 8

62% of life sciences companies have a formal DEI policy, but only 36% have dedicated DEI officers

Statistic 9

The number of women-led biotech startups increased by 12% in 2022, yet they still received only 4% of total venture funding

Statistic 10

The percentage of LGBTQ+ individuals working in biotech is estimated at 8%, with only 3% in senior leadership

Statistic 11

65% of biotech companies have established employee resource groups focused on diversity, equity, and inclusion efforts

Statistic 12

Only 9% of senior research roles in life sciences are held by professionals from indigenous backgrounds

Statistic 13

71% of scientists agree that diverse teams produce more innovative solutions

Statistic 14

52% of life sciences firms report they have more work to do to improve diversity among their staff

Statistic 15

70% of life sciences employers have expanded their DEI initiatives since 2020

Statistic 16

The racial diversity percentage in the biotech workforce has increased by 4% over five years, yet remains underrepresented at 15%

Statistic 17

85% of life sciences companies believe that improving diversity will help attract and retain top talent

Statistic 18

The percentage of biotech research papers authored by diverse teams increased by 8% in the last three years

Statistic 19

Only 19% of clinical leaders are from underrepresented backgrounds

Statistic 20

The percentage of women in R&D roles increased by 6% over the past five years, but gender parity is still not achieved

Statistic 21

44% of life sciences organizations have integrated DEI principles into their core business strategies

Statistic 22

The representation of indigenous peoples in biotech senior roles is less than 1%

Statistic 23

50% of life sciences companies report ongoing challenges in achieving racial and ethnic diversity

Statistic 24

Women represent approximately 40% of the healthcare workforce overall, but only 25% in senior leadership roles

Statistic 25

80% of senior biotech executives say they are committed to increasing diversity, but only 30% have concrete initiatives in place

Statistic 26

65% of biotech HR managers report difficulties in recruiting diverse candidates

Statistic 27

68% of biotech companies have implemented mentorship programs specifically for underrepresented groups

Statistic 28

The number of journals publishing diversity-themed research in biotech increased by 10% over the last three years

Statistic 29

77% of life sciences students from minority backgrounds feel they lack sufficient mentorship opportunities

Statistic 30

Training programs focusing on cultural competence are present in 55% of biotech companies

Statistic 31

72% of biotech companies have DEI-related diversity hiring targets, but only 44% meet or exceed those targets

Statistic 32

The percentage of leadership identifying as LGBTQ+ in life sciences is approximately 4%

Statistic 33

The proportion of biotech workforce with disabilities is about 3%, with efforts underway to increase accessibility

Statistic 34

45% of life sciences employees report experiencing some form of workplace bias

Statistic 35

60% of employees in life sciences consider DEI initiatives important for company culture

Statistic 36

47% of employees in the life sciences believe that management does not adequately address diversity issues

Statistic 37

14% of women and 8% of men in the industry report experiencing sexual harassment at work

Statistic 38

65% of employees believe that diversity efforts should be more transparent and accessible

Statistic 39

Companies with inclusive cultures have 30% higher employee satisfaction scores

Statistic 40

85% of employees believe diversity and inclusion efforts improve their job satisfaction

Statistic 41

In a survey, 58% of biotech employees say leadership needs to improve transparency regarding diversity goals

Statistic 42

The incidence of bias-related complaints in biotech workplaces increased by 12% from 2020 to 2022

Statistic 43

Programs aimed at increasing career diversity show that 40% of underrepresented candidates report feeling more prepared for biotech careers

Statistic 44

Women hold approximately 30% of leadership roles in the life sciences industry

Statistic 45

The percentage of Underrepresented Minorities (URMs) in STEM fields, including life sciences, is 28%

Statistic 46

Female founders in the biotech sector received only 2% of venture capital funding in 2022

Statistic 47

Approximately 33% of clinical trial participants are from minority backgrounds, despite minorities representing 40% of the population

Statistic 48

The representation of women in patent filings related to biotechnology is 35%

Statistic 49

Only 14% of funding for life sciences research is allocated to projects led by women

Statistic 50

The percentage of women in biotech leadership positions increased by 5% since 2019, but representation still remains below 40%

Statistic 51

Minority women account for only 2% of executive leadership roles in biotech

Statistic 52

The participation of minority students in biotech internships increased by 15% in the past three years, yet they still comprise only 10% of total internships

Statistic 53

The participation of women in biotech research publications increased by 5% in the last four years, but they remain underrepresented in senior authorship roles

Statistic 54

Companies with diverse leadership are 25% more likely to outperform their peers financially

Statistic 55

Companies with gender-diverse boards are 21% more likely to experience above-average profitability

Statistic 56

55% of life sciences professionals believe that increasing diversity leads to better research outcomes

Statistic 57

28% of clinical trial sites are located in underrepresented communities, despite these communities comprising 40% of the population

Statistic 58

Companies in the top quartile for racial and ethnic diversity are 35% more likely to have financial returns above their industry norms

Statistic 59

Organizations with a clear DEI strategy are 50% more likely to see positive impacts on innovation

Statistic 60

78% of biotech executives agree that increasing diversity enhances innovation and research quality

Statistic 61

73% of clinicians agree that diverse clinical trial populations lead to more effective treatments

Statistic 62

83% of biotech companies acknowledge the importance of diverse clinical trial data for regulatory approvals

Statistic 63

50% of biotech firms report that their DEI efforts have positively impacted innovation, though only 25% have formalized metrics

Statistic 64

80% of life sciences job applicants prioritize a company's commitment to diversity and inclusion

Statistic 65

Establishing DEI metrics results in a 20% improvement in accountability and progress tracking

Statistic 66

42% of life sciences companies plan to increase their DEI budgets by more than 20% in 2024

Statistic 67

69% of life sciences professionals agree that DEI initiatives should be integrated into all organizational levels

Slide 1 of 67

Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

Women hold approximately 30% of leadership roles in the life sciences industry
Minority representation in biotech executive roles is around 10%
Companies with diverse leadership are 25% more likely to outperform their peers financially
Only 12% of drug researchers are from underrepresented racial and ethnic groups
45% of life sciences employees report experiencing some form of workplace bias
The percentage of Underrepresented Minorities (URMs) in STEM fields, including life sciences, is 28%
60% of employees in life sciences consider DEI initiatives important for company culture
22% of biotech firms have explicitly stated targets for increasing diversity in their leadership
Female founders in the biotech sector received only 2% of venture capital funding in 2022
Approximately 33% of clinical trial participants are from minority backgrounds, despite minorities representing 40% of the population
The representation of women in patent filings related to biotechnology is 35%
73% of life sciences companies have implemented DEI training programs
Only 11% of senior management positions in life sciences are held by people from underrepresented backgrounds

Despite the clear link between diversity and innovation, the life sciences industry continues to grapple with underrepresentation, with women occupying only 30% of leadership roles and minorities making up just 10% of biotech executives, highlighting an urgent need for growth and commitment in advancing equity and inclusion.

Diversity in Leadership and Workforce

Minority representation in biotech executive roles is around 10%
Only 12% of drug researchers are from underrepresented racial and ethnic groups
22% of biotech firms have explicitly stated targets for increasing diversity in their leadership
73% of life sciences companies have implemented DEI training programs
Only 11% of senior management positions in life sciences are held by people from underrepresented backgrounds
The percentage of Black employees in the biotech industry is approximately 4%
The average tenure of minority executives in biotech is 2.8 years, shorter than their non-minority counterparts by 1.5 years
62% of life sciences companies have a formal DEI policy, but only 36% have dedicated DEI officers
The number of women-led biotech startups increased by 12% in 2022, yet they still received only 4% of total venture funding
The percentage of LGBTQ+ individuals working in biotech is estimated at 8%, with only 3% in senior leadership
65% of biotech companies have established employee resource groups focused on diversity, equity, and inclusion efforts
Only 9% of senior research roles in life sciences are held by professionals from indigenous backgrounds
71% of scientists agree that diverse teams produce more innovative solutions
52% of life sciences firms report they have more work to do to improve diversity among their staff
70% of life sciences employers have expanded their DEI initiatives since 2020
The racial diversity percentage in the biotech workforce has increased by 4% over five years, yet remains underrepresented at 15%
85% of life sciences companies believe that improving diversity will help attract and retain top talent
The percentage of biotech research papers authored by diverse teams increased by 8% in the last three years
Only 19% of clinical leaders are from underrepresented backgrounds
The percentage of women in R&D roles increased by 6% over the past five years, but gender parity is still not achieved
44% of life sciences organizations have integrated DEI principles into their core business strategies
The representation of indigenous peoples in biotech senior roles is less than 1%
50% of life sciences companies report ongoing challenges in achieving racial and ethnic diversity
Women represent approximately 40% of the healthcare workforce overall, but only 25% in senior leadership roles
80% of senior biotech executives say they are committed to increasing diversity, but only 30% have concrete initiatives in place
65% of biotech HR managers report difficulties in recruiting diverse candidates
68% of biotech companies have implemented mentorship programs specifically for underrepresented groups
The number of journals publishing diversity-themed research in biotech increased by 10% over the last three years
77% of life sciences students from minority backgrounds feel they lack sufficient mentorship opportunities
Training programs focusing on cultural competence are present in 55% of biotech companies
72% of biotech companies have DEI-related diversity hiring targets, but only 44% meet or exceed those targets
The percentage of leadership identifying as LGBTQ+ in life sciences is approximately 4%
The proportion of biotech workforce with disabilities is about 3%, with efforts underway to increase accessibility

Diversity in Leadership and Workforce Interpretation

Despite growing awareness and some initiatives, minority representation in biotech remains a stark reminder that the industry’s commitment to diversity is more talk than transformative action, as underrepresented groups still face barriers to leadership, funding, and inclusion in the very innovation they help inspire.

Employee Experiences and Inclusivity

45% of life sciences employees report experiencing some form of workplace bias
60% of employees in life sciences consider DEI initiatives important for company culture
47% of employees in the life sciences believe that management does not adequately address diversity issues
14% of women and 8% of men in the industry report experiencing sexual harassment at work
65% of employees believe that diversity efforts should be more transparent and accessible
Companies with inclusive cultures have 30% higher employee satisfaction scores
85% of employees believe diversity and inclusion efforts improve their job satisfaction
In a survey, 58% of biotech employees say leadership needs to improve transparency regarding diversity goals
The incidence of bias-related complaints in biotech workplaces increased by 12% from 2020 to 2022
Programs aimed at increasing career diversity show that 40% of underrepresented candidates report feeling more prepared for biotech careers

Employee Experiences and Inclusivity Interpretation

Despite widespread recognition of the importance of DEI in life sciences, with 60% deeming it vital to company culture, nearly half experience workplace bias and a mere 14% of women report sexual harassment—highlighting a stark disconnect between corporate aspirations and the lived realities that hinder inclusive progress.

Gender and Underrepresented Group Representation

Women hold approximately 30% of leadership roles in the life sciences industry
The percentage of Underrepresented Minorities (URMs) in STEM fields, including life sciences, is 28%
Female founders in the biotech sector received only 2% of venture capital funding in 2022
Approximately 33% of clinical trial participants are from minority backgrounds, despite minorities representing 40% of the population
The representation of women in patent filings related to biotechnology is 35%
Only 14% of funding for life sciences research is allocated to projects led by women
The percentage of women in biotech leadership positions increased by 5% since 2019, but representation still remains below 40%
Minority women account for only 2% of executive leadership roles in biotech
The participation of minority students in biotech internships increased by 15% in the past three years, yet they still comprise only 10% of total internships
The participation of women in biotech research publications increased by 5% in the last four years, but they remain underrepresented in senior authorship roles

Gender and Underrepresented Group Representation Interpretation

Despite modest gains over recent years, the stark underrepresentation of women and minorities—ranging from only 2% of biotech VC funding to 30% of leadership roles—reminds us that equitable inclusion in life sciences remains a vital frontier demanding more than just incremental progress.

Impact of Diversity on Business Performance

Companies with diverse leadership are 25% more likely to outperform their peers financially
Companies with gender-diverse boards are 21% more likely to experience above-average profitability
55% of life sciences professionals believe that increasing diversity leads to better research outcomes
28% of clinical trial sites are located in underrepresented communities, despite these communities comprising 40% of the population
Companies in the top quartile for racial and ethnic diversity are 35% more likely to have financial returns above their industry norms
Organizations with a clear DEI strategy are 50% more likely to see positive impacts on innovation
78% of biotech executives agree that increasing diversity enhances innovation and research quality
73% of clinicians agree that diverse clinical trial populations lead to more effective treatments
83% of biotech companies acknowledge the importance of diverse clinical trial data for regulatory approvals
50% of biotech firms report that their DEI efforts have positively impacted innovation, though only 25% have formalized metrics

Impact of Diversity on Business Performance Interpretation

Embracing diversity, equity, and inclusion isn't just a moral imperative for the life sciences industry—it’s a proven catalyst for innovation, better research outcomes, and markedly improved financial performance, yet persistent gaps in representation and strategic measurement suggest the journey toward true inclusivity remains a work in progress.

Organizational Commitment to Diversity Initiatives

80% of life sciences job applicants prioritize a company's commitment to diversity and inclusion
Establishing DEI metrics results in a 20% improvement in accountability and progress tracking
42% of life sciences companies plan to increase their DEI budgets by more than 20% in 2024
69% of life sciences professionals agree that DEI initiatives should be integrated into all organizational levels

Organizational Commitment to Diversity Initiatives Interpretation

With 80% of applicants valuing diversity, a 20% boost in DEI accountability, over a fifth of firms ramping up budgets, and nearly 70% advocating for organization-wide integration, the life sciences industry is signaling that inclusivity isn't just ethical—it's essential for innovation and talent retention in 2024.